The documented association between increased serum Se concentrations and type 2 diabetes could be a consequence of insulin resistance leading to increased hepatic biosynthesis of SELENOP due to abrogation of insulin-mediated SELENOP suppression, i.e., a question of reverse causality, potentially a function of protecting the cardiovascular system [51]. This evidence concerns the gene SELENOP and type 2 diabetes mellitus.